Alcoholic liver disease

These recommendations provide a data-supported approach. They are based on the following: (1) formal review and analysis of the recently published world literature on the topic (Medline search); (2) American College of Physicians Manual for Assessing Health Practices and Designing Practice Guidelines1; (3) guideline policies, including the AASLD Policy on the development and use of Practice Guidelines and the American Gastroenterological Association Policy Statement on Guidelines2; and (4) the experience of the authors in the specified topic. Intended for use by physicians, these recommendations suggest preferred approaches to the diagnostic, therapeutic, and preventive aspects of care. They are intended to be flexible, in contrast to standards of care, which are inflexible policies to be followed in every case. Specific recommendations are based on relevant published information. To more fully characterize the quality of evidence supporting recommendations, the Practice Guideline Committee of the AASLD requires a Class (reflecting benefit versus risk) and Level (assessing strength or certainty) of Evidence to be assigned and reported with each recommendation (Table 1, adapted from the American College of Cardiology and the American Heart Association Practice Guidelines).3,4

[1]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[2]  S. Leucht,et al.  Opioid antagonists for alcohol dependence. , 2010, The Cochrane database of systematic reviews.

[3]  P. Christoffersen,et al.  Histological changes in human liver biopsies from chronic alcoholics. , 2009, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.

[4]  G. Gores,et al.  A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis. , 2008, Gastroenterology.

[5]  S. Pol,et al.  Influence of liver biopsy on abstinence in alcohol-dependent patients. , 2008, Alcohol and alcoholism.

[6]  H. Saconato,et al.  Systematic review: glucocorticosteroids for alcoholic hepatitis – a Cochrane Hepato‐Biliary Group systematic review with meta‐analyses and trial sequential analyses of randomized clinical trials , 2008, Alimentary pharmacology & therapeutics.

[7]  P. Deltenre,et al.  Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids. , 2008, Journal of hepatology.

[8]  Julian P T Higgins,et al.  Recent developments in meta‐analysis , 2008, Statistics in medicine.

[9]  G. Gasbarrini,et al.  Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study , 2007, The Lancet.

[10]  Y. Israel,et al.  Assessment of Prognostic Factors in Alcoholic Liver Disease: Toward a Global Quantitative Expression of Severity , 2007, Hepatology.

[11]  B. Wolff,et al.  MARS dialysis in decompensated alcoholic liver disease: A single‐center experience , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[12]  Alexandre Louvet,et al.  The Lille model: A new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids , 2007, Hepatology.

[13]  C. Ripoll,et al.  Prognostic value of hepatic venous pressure gradient for in‐hospital mortality of patients with severe acute alcoholic hepatitis , 2007, Alimentary pharmacology & therapeutics.

[14]  F. Wurst,et al.  BIOMARKER: Phosphatidylethanol as a sensitive and specific biomarker—comparison with gamma‐glutamyl transpeptidase, mean corpuscular volume and carbohydrate‐deficient transferrin , 2007, Addiction biology.

[15]  D. Kivlahan,et al.  Alcohol screening scores and risk of hospitalizations for GI conditions in men. , 2007, Alcoholism, clinical and experimental research.

[16]  O. Niemelä Biomarkers in alcoholism. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[17]  Roger Williams,et al.  Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis , 2007, Hepatology.

[18]  J. O'grady,et al.  Liver transplantation alcohol related liver disease: (deliberately) stirring a hornet’s nest! , 2006, Gut.

[19]  F. Tagliaro,et al.  Carbohydrate-deficient transferrin (CDT) as a marker of alcohol abuse: a critical review of the literature 2001-2005. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[20]  J. Brick,et al.  Standardization of alcohol calculations in research. , 2006, Alcoholism, clinical and experimental research.

[21]  A. Soultati,et al.  Predicting utility of a model for end stage liver disease in alcoholic liver disease. , 2006, World journal of gastroenterology.

[22]  David Couper,et al.  Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. , 2006, JAMA.

[23]  B. Portmann,et al.  Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis--a randomised clinical trial. , 2006, Journal of hepatology.

[24]  A. McCullough,et al.  Steroids or cocktails for alcoholic hepatitis. , 2006, Journal of hepatology.

[25]  M. Plauth,et al.  ESPEN Guidelines on Enteral Nutrition: Liver disease. , 2006, Clinical nutrition.

[26]  S. Jaber,et al.  Are preoperative patterns of alcohol consumption predictive of relapse after liver transplantation for alcoholic liver disease? , 2005, Transplant international : official journal of the European Society for Organ Transplantation.

[27]  M. Aalto,et al.  Use of laboratory markers and the audit questionnaire by primary care physicians to detect alcohol abuse by patients. , 2005, Alcohol and alcoholism.

[28]  P. Mathurin Is alcoholic hepatitis an indication for transplantation? Current management and outcomes , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[29]  C. Gluud,et al.  Milk Thistle for Alcoholic and/or Hepatitis B or C Liver Diseases—A Systematic Cochrane Hepato-Biliary Group Review with Meta-Analyses of Randomized Clinical Trials , 2005, The American Journal of Gastroenterology.

[30]  Neil Skolnik,et al.  Helping Patients Who Drink Too Much , 2005 .

[31]  M. Soyka,et al.  Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin. , 2005, Addiction.

[32]  G. Friedman,et al.  Alcohol drinking and risk of hospitalization for heart failure with and without associated coronary artery disease. , 2005, The American journal of cardiology.

[33]  P. Hayes,et al.  Alcoholic hepatitis: from pathogenesis to treatment , 2005, Current medical research and opinion.

[34]  L S Murray,et al.  Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score , 2005, Gut.

[35]  C. De Simone,et al.  Beneficial Effects of a Probiotic VSL#3 on Parameters of Liver Dysfunction in Chronic Liver Diseases , 2005, Journal of clinical gastroenterology.

[36]  Paul L Doering,et al.  Acamprosate for the treatment of alcohol dependence. , 2005, Clinical therapeutics.

[37]  P. Burra,et al.  Liver transplantation in alcoholic patients , 2005, Transplant international : official journal of the European Society for Organ Transplantation.

[38]  B. Runyon,et al.  MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis. , 2005, Journal of hepatology.

[39]  C. Gluud,et al.  Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis. , 2005, The Cochrane database of systematic reviews.

[40]  M. Pedrosa,et al.  Colchicine treatment of alcoholic cirrhosis: a randomized, placebo-controlled clinical trial of patient survival. , 2005, Gastroenterology.

[41]  K. Punnonen,et al.  Biomarkers of alcohol consumption in patients classified according to the degree of liver disease severity , 2005, Scandinavian journal of clinical and laboratory investigation.

[42]  E. D’Amico,et al.  Identification of and Guidance for Problem Drinking by General Medical Providers: Results From a National Survey , 2005, Medical care.

[43]  F. Wurst,et al.  Emerging biomarkers: new directions and clinical applications. , 2005, Alcoholism, clinical and experimental research.

[44]  W. Kim,et al.  MELD accurately predicts mortality in patients with alcoholic hepatitis , 2005, Hepatology.

[45]  C. M. Leevy,et al.  Nutritional aspects of alcoholic liver disease. , 2005, Clinics in liver disease.

[46]  M. Tosti,et al.  Correlation of alcohol consumption with liver histological features in non-cirrhotic patients , 2005, European journal of gastroenterology & hepatology.

[47]  E. Cabré,et al.  Combining steroids with enteral nutrition: a better therapeutic strategy for severe alcoholic hepatitis? Results of a pilot study , 2004, European journal of gastroenterology & hepatology.

[48]  Gurvaneet Randhawa,et al.  Screening and behavioral counseling interventions in primary care to reduce alcohol misuse. , 2004, American family physician.

[49]  C. Duvoux,et al.  Predictive factors of alcohol relapse after orthotopic liver transplantation for alcoholic liver disease. , 2004, Gastroenterologie clinique et biologique.

[50]  Jin-yan Luo,et al.  Risk factors for alcoholic liver disease in China. , 2004, World journal of gastroenterology.

[51]  J. Levitsky,et al.  Diagnosis and therapy of alcoholic liver disease. , 2004, Seminars in liver disease.

[52]  J. Tolstrup,et al.  Alcohol and cirrhosis: dose--response or threshold effect? , 2004, Journal of hepatology.

[53]  J. Balldin,et al.  High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking. , 2004, Alcohol and alcoholism.

[54]  U. John,et al.  Laboratory markers carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean corpuscular volume are not useful as screening tools for high-risk drinking in the general population: results from the Study of Health in Pomerania (SHIP). , 2004, Alcoholism, clinical and experimental research.

[55]  Adnan Said,et al.  Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. , 2004, Journal of hepatology.

[56]  P. Broët,et al.  A double‐blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis , 2004, Hepatology.

[57]  T. Wright,et al.  Risks of a range of alcohol intake on hepatitis C‐related fibrosis , 2004, Hepatology.

[58]  G. Gores,et al.  A Pilot Study of the Safety and Tolerability of Etanercept in Patients with Alcoholic Hepatitis , 2004, American Journal of Gastroenterology.

[59]  C. Lieber New concepts of the pathogenesis of alcoholic liver disease lead to novel treatments , 2004, Current gastroenterology reports.

[60]  Y. Mahida,et al.  A pilot study to investigate the use of oxpentifylline (pentoxifylline) and thalidomide in portal hypertension secondary to alcoholic cirrhosis , 2004, Alimentary pharmacology & therapeutics.

[61]  D. Valla,et al.  Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone , 2003, Hepatology.

[62]  J. Whitfield,et al.  Combining carbohydrate-deficient transferrin and gamma-glutamyltransferase to increase diagnostic accuracy for problem drinking. , 2003, Alcohol and alcoholism.

[63]  Aniruddha M. Deshpande,et al.  Standardized Reporting of Clinical Practice Guidelines: A Proposal from the Conference on Guideline Standardization , 2003, Annals of Internal Medicine.

[64]  T. Tran,et al.  The role of the discriminant factor in the assessment and treatment of alcoholic hepatitis , 2003, American Journal of Gastroenterology.

[65]  T. Ide,et al.  Severe alcoholic hepatitis successfully treated by leukocytapheresis: a case report. , 2003, Alcoholism, clinical and experimental research.

[66]  D. Arveiler,et al.  Joint use of clinical parameters, biological markers and CAGE questionnaire for the identification of heavy drinkers in a large population-based sample. , 2003, Alcohol and alcoholism.

[67]  D. Valla,et al.  Five‐year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence , 2003, Liver international : official journal of the International Association for the Study of the Liver.

[68]  A. Moser,et al.  Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease , 2003, Hepatology.

[69]  C. Lieber Hepatitis C and alcohol. , 2003, Journal of clinical gastroenterology.

[70]  Majid Ezzati,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[71]  P. Perney,et al.  Wine consumption is not associated with a decreased risk of alcoholic cirrhosis in heavy drinkers. , 2002, Alcohol and alcoholism.

[72]  C. Lieber S-adenosyl-L-methionine: its role in the treatment of liver disorders. , 2002, The American journal of clinical nutrition.

[73]  F. Corrales,et al.  Importance of a deficiency in S-adenosyl-L-methionine synthesis in the pathogenesis of liver injury. , 2002, The American journal of clinical nutrition.

[74]  A. Rougemont,et al.  Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study. , 2002, Journal of hepatology.

[75]  Katsuyoshi Ito,et al.  Cirrhosis: A Modified Caudate-to-Right-Lobe Ratio , 2001 .

[76]  C. Eriksson,et al.  Laboratory tests for acute alcohol consumption: results of the WHO/ISBRA Study on State and Trait Markers of Alcohol Use and Dependence. , 2002, Alcoholism, clinical and experimental research.

[77]  T. Reynolds,et al.  Duplex Doppler Ultrasound of the Hepatic Artery in Patients With Acute Alcoholic Hepatitis , 2002, Journal of clinical gastroenterology.

[78]  T. Sørensen,et al.  Lower risk for alcohol‐induced cirrhosis in wine drinkers , 2002, Hepatology.

[79]  R. Carithers,et al.  Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. , 2002, Journal of hepatology.

[80]  John B Saunders,et al.  CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project. , 2002, Alcoholism, clinical and experimental research.

[81]  M. Riggs,et al.  Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis , 2002, BMC gastroenterology.

[82]  D. Altman,et al.  Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice , 2002, Journal of health services research & policy.

[83]  Edward A. Graviss,et al.  A systematic review of the diagnostic accuracy of physical examination for the detection of cirrhosis , 2001, BMC Medical Informatics Decis. Mak..

[84]  T. J. Peters,et al.  Alcoholic skeletal muscle myopathy: definitions, features, contribution of neuropathy, impact and diagnosis , 2001, European journal of neurology.

[85]  P. Sharpe,et al.  Biochemical detection and monitoring of alcohol abuse and abstinence , 2001, Annals of clinical biochemistry.

[86]  G. Gores,et al.  Pathogenesis, diagnosis, and treatment of alcoholic liver disease. , 2001, Mayo Clinic proceedings.

[87]  T. Starzl,et al.  Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence. , 2001, Transplantation.

[88]  V. Vilgrain Ultrasound of diffuse liver disease and portal hypertension , 2001, European Radiology.

[89]  B. Grant,et al.  The critical dimension of ethnicity in liver cirrhosis mortality statistics. , 2001, Alcoholism, clinical and experimental research.

[90]  Marie-Cecile O. Tidwell,et al.  Alcohol and gambling pathology among U.S. adults: prevalence, demographic patterns and comorbidity. , 2001, Journal of studies on alcohol.

[91]  K. Ikejima,et al.  Sex difference in alcohol-related organ injury. , 2001, Alcoholism, clinical and experimental research.

[92]  J. Neuberger,et al.  Orthotopic liver transplantation for alcoholic liver disease: A retrospective analysis of survival, recidivism, and risk factors predisposing to recidivism , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[93]  M. Giacca,et al.  Genetic Determinants of Ethanol-Induced Liver Damage , 2001, Molecular medicine.

[94]  G Pozzato,et al.  Gender differences in pharmacokinetics of alcohol. , 2001, Alcoholism, clinical and experimental research.

[95]  A. Mihas,et al.  Nutritional therapy for alcoholic hepatitis: new life for an old idea. , 2001, Gastroenterology.

[96]  W. Miller,et al.  How effective is alcoholism treatment in the United States? , 2001, Journal of studies on alcohol.

[97]  C. Day Apoptosis in alcoholic hepatitis: a novel therapeutic target? , 2001, Journal of hepatology.

[98]  M. Ramstedt Per capita alcohol consumption and liver cirrhosis mortality in 14 European countries. , 2001, Addiction.

[99]  T M Therneau,et al.  A model to predict survival in patients with end‐stage liver disease , 2001, Hepatology.

[100]  L. Seeff,et al.  The Relationship of Acute Transfusion-Associated Hepatitis to the Development of Cirrhosis in the Presence of Alcohol Abuse , 2001, Annals of Internal Medicine.

[101]  T. Reynolds,et al.  Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. , 2000, Gastroenterology.

[102]  H. Okazaki,et al.  Discrimination of alcoholic from virus-induced cirrhosis on MR imaging. , 2000, AJR. American journal of roentgenology.

[103]  C. Day Who Gets Alcoholic Liver Disease: Nature or Nurture? , 2000, Journal of the Royal College of Physicians of London.

[104]  E. Vartiainen,et al.  Dose response of laboratory markers to alcohol consumption in a general population. , 2000, American journal of epidemiology.

[105]  S. Kihara,et al.  Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. , 2000, Blood.

[106]  A. Palmer,et al.  The long-term cost-effectiveness of improving alcohol abstinence with adjuvant acamprosate. , 2000, Alcohol and alcoholism.

[107]  R. Schwan,et al.  Objective diagnosis of alcohol abuse: compared values of carbohydrate-deficient transferrin (CDT), gamma-glutamyl transferase (GGT), and mean corpuscular volume (MCV). , 2000, Alcoholism, clinical and experimental research.

[108]  L. Yanek,et al.  Detecting symptoms of alcohol abuse in primary care settings. , 2000, Archives of family medicine.

[109]  P. O'Connor,et al.  Screening for alcohol problems in primary care: a systematic review. , 2000, Archives of internal medicine.

[110]  L. Midanik,et al.  The effect of screening on prevalence estimates of alcohol dependence and social consequences. , 2000, Journal of studies on alcohol.

[111]  E. Cabré,et al.  Short‐ and long‐term outcome of severe alcohol‐induced hepatitis treated with steroids or enteral nutrition: A multicenter randomized trial , 2000, Hepatology.

[112]  P. Bedossa,et al.  Appropriateness of liver biopsy. , 2000, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[113]  A. Neskovic,et al.  Early changes in left ventricular function in chronic asymptomatic alcoholics: relation to the duration of heavy drinking. , 2000, Journal of the American College of Cardiology.

[114]  T. Kuroki,et al.  Contribution of hepatitis C virus to the progression of alcoholic liver disease. , 2000, Alcoholism, clinical and experimental research.

[115]  C. Bodian,et al.  Accuracy and significance of computed tomographic scan assessment of hepatic volume in patients undergoing liver transplantation. , 2000, Transplantation.

[116]  D. Crabb,et al.  Pathogenesis of alcoholic liver disease: newer mechanisms of injury. , 1999, The Keio journal of medicine.

[117]  S. Newton,et al.  Recidivism and return to work posttransplant. Recipients with substance abuse histories. , 1999, Journal of substance abuse treatment.

[118]  M. Plauth,et al.  Liver cirrhosis: rationale and modalities for nutritional support--the European Society of Parenteral and Enteral Nutrition consensus and beyond. , 1999, Current opinion in clinical nutrition and metabolic care.

[119]  J. Rodés,et al.  S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. , 1999, Journal of hepatology.

[120]  A. McCullough,et al.  Treatment of alcoholic hepatitis. , 1998, Clinics in liver disease.

[121]  K. Mullen,et al.  POTENTIAL NEW THERAPIES FOR ALCOHOLIC LIVER DISEASE , 1998 .

[122]  R. Wiesner,et al.  Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. , 1998, Transplantation.

[123]  E. Mezey Dietary fat and alcoholic liver disease , 1998, Hepatology.

[124]  S. Cantor,et al.  Ethnic and Sex Bias in Primary Care Screening Tests for Alcohol Use Disorders , 1998, Annals of Internal Medicine.

[125]  D. V. van Thiel,et al.  Liver transplantation for alcoholic liver disease. , 1998, Hepato-gastroenterology.

[126]  G. Brandi,et al.  Drinking habits as cofactors of risk for alcohol induced liver damage , 1997, Gut.

[127]  Gordon S. Smith,et al.  The accuracy of the CAGE, the Brief Michigan Alcoholism Screening Test, and the Alcohol Use Disorders Identification Test in screening trauma center patients for alcoholism. , 1997, The Journal of trauma.

[128]  R. Caetano,et al.  DSM-IV alcohol dependence and drinking in the U.S. population: a risk analysis. , 1997, Annals of epidemiology.

[129]  G. Corrao,et al.  Are the recent trends in liver cirrhosis mortality affected by the changes in alcohol consumption? Analysis of latency period in European countries. , 1997, Journal of studies on alcohol.

[130]  B. Grant Barriers to alcoholism treatment: reasons for not seeking treatment in a general population sample. , 1997, Journal of studies on alcohol.

[131]  R. Groszmann,et al.  Effects of ethanol consumption on hepatic hemodynamics in patients with alcoholic cirrhosis. , 1997, Gastroenterology.

[132]  F. Capron,et al.  Excess weight risk factor for alcoholic liver disease , 1997, Hepatology.

[133]  T. Reed,et al.  Genetic predisposition to organ-specific endpoints of alcoholism. , 1996, Alcoholism, clinical and experimental research.

[134]  D MacKenzie,et al.  Identifying hazardous or harmful alcohol use in medical admissions: a comparison of audit, cage and brief mast. , 1996, Alcohol and alcoholism.

[135]  B Carstensen,et al.  Accuracy of clinical diagnosis of cirrhosis among alcohol-abusing men. , 1996, Journal of clinical epidemiology.

[136]  C. Degott,et al.  Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. , 1996, Gastroenterology.

[137]  T. Sørensen,et al.  Prediction of risk of liver disease by alcohol intake, sex, and age: A prospective population study , 1996, Hepatology.

[138]  C. Erickson,et al.  Conference summary: Consensus Conference on Alcohol Dependence and the Role of Pharmacotherapy in its Treatment. , 1996, Alcoholism, clinical and experimental research.

[139]  M. Perola,et al.  Early perivenular fibrogenesis--precirrhotic lesions among moderate alcohol consumers and chronic alcoholics. , 1995, Journal of hepatology.

[140]  M. Bennett,et al.  Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver , 1995, The Lancet.

[141]  G. van Melle,et al.  Screening for excessive alcohol drinking. Comparative value of carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean corpuscular volume. , 1995, Archives of internal medicine.

[142]  S. Wickramasinghe,et al.  Ethnic differences in the biological consequences of alcohol abuse: a comparison between south Asian and European males. , 1995, Alcohol and alcoholism.

[143]  E. Christensen,et al.  Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables. , 1995, Gut.

[144]  S. Shapiro,et al.  Alcohol consumption and the risk of major upper gastrointestinal bleeding. , 1995, The American journal of gastroenterology.

[145]  Thomas E. Moritz,et al.  Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration Cooperative Studies. , 1995, Alcoholism, clinical and experimental research.

[146]  J. Kitchens,et al.  Does this patient have an alcohol problem? , 1994, JAMA.

[147]  E. Villanueva,et al.  Comparison of the CAGE questionnaire versus some biochemical markers in the diagnosis of alcoholism. , 1994, Alcohol and alcoholism.

[148]  H. Bonkovsky,et al.  Nutritional supplementation in chronic liver disease: An analytical review , 1994, Hepatology.

[149]  A. Paton,et al.  The risk of alcohol. , 1993, Addiction.

[150]  G. Bird Investigation of alcoholic liver disease. , 1993, Bailliere's clinical gastroenterology.

[151]  J. Nicolás,et al.  Relationship between ethanol-related diseases and nutritional status in chronically alcoholic men. , 1993, Alcohol and alcoholism.

[152]  A. Penttilä,et al.  Alcohol consumption and alcoholic liver disease: evidence of a threshold level of effects of ethanol. , 1993, Alcoholism, clinical and experimental research.

[153]  J B Saunders,et al.  Epidemiology of alcoholic liver disease. , 1993, Bailliere's clinical gastroenterology.

[154]  O. Aasland,et al.  Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. , 1993, Addiction.

[155]  D. Bunout,et al.  Controlled trial on nutrition supplementation in outpatients with symptomatic alcoholic cirrhosis. , 1993, JPEN. Journal of parenteral and enteral nutrition.

[156]  H. Prytz,et al.  Identification of alcoholic liver disease or hidden alcohol abuse in patients with elevated liver enzymes , 1993, Journal of internal medicine.

[157]  C. Day,et al.  Genetic predisposition to alcoholic liver disease. , 1992, Gut.

[158]  J M Scheller,et al.  The rational clinical examination. , 1992, JAMA.

[159]  K. Brown Alcohol hepatotoxicity: a genotypic predisposition? , 1992, The American journal of gastroenterology.

[160]  J. Benhamou,et al.  A randomized trial of prednisolone in patients with severe alcoholic hepatitis. , 1992, The New England journal of medicine.

[161]  E. Mezey Interaction Between Alcohol and Nutrition in the Pathogenesis of Alcoholic Liver Disease , 1991, Seminars in liver disease.

[162]  G. S. Smith,et al.  A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. I. Short-term effects on liver function. , 1991, The American journal of gastroenterology.

[163]  R. Moore,et al.  Alcohol abuse: comparison of two methods for assessing its prevalence and associated morbidity in hospitalized patients. , 1991, The American journal of medicine.

[164]  K. Ishak,et al.  Alcoholic liver disease: pathologic, pathogenetic and clinical aspects. , 1991, Alcoholism, clinical and experimental research.

[165]  P. Gartside,et al.  Prognostic factors in alcoholic liver disease. VA Cooperative Study Group. , 1991, The American journal of gastroenterology.

[166]  C. Turner,et al.  How much alcohol is in a 'standard drink'? An analysis of 125 studies. , 1990, British journal of addiction.

[167]  T. Imperiale,et al.  Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials. , 1990, Annals of internal medicine.

[168]  G. Marchesini,et al.  Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group. , 1990, Journal of hepatology.

[169]  G. Marchesini,et al.  Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy: A randomized double-blind casein-controlled trial☆ , 1990 .

[170]  C. Lieber,et al.  High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. , 1990, The New England journal of medicine.

[171]  M. Zillikens,et al.  Effect of a late evening meal on nitrogen balance in patients with cirrhosis of the liver. , 1989, BMJ.

[172]  B. Schneider,et al.  Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. , 1989, Journal of hepatology.

[173]  R. Carithers,et al.  Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. , 1989, Annals of internal medicine.

[174]  G. Geller,et al.  Prevalence, detection, and treatment of alcoholism in hospitalized patients. , 1989, JAMA.

[175]  K. Ishak,et al.  Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. , 1988, Gastroenterology.

[176]  Y. Israel,et al.  LONG-TERM TREATMENT OF ALCOHOLIC LIVER DISEASE WITH PROPYLTHIOURACIL , 1988, The Lancet.

[177]  D. Bunout,et al.  Overweight as a risk factor or a predictive sign of histological liver damage in alcoholics. , 1988, The American journal of clinical nutrition.

[178]  H. Michel,et al.  [Treatment of acute alcoholic hepatitis with prednisolone. 45 patients]. , 1987, Presse medicale.

[179]  B. Ducot,et al.  Interobserver agreement in the physical diagnosis of alcoholic liver disease , 1987, Digestive Diseases and Sciences.

[180]  M. Eckardt,et al.  Biological correlates and detection of alcohol abuse and alcoholism , 1986, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[181]  R. N. Macsween,et al.  Histologic Spectrum of Alcoholic Liver Disease , 1986, Seminars in liver disease.

[182]  B. Lacour,et al.  Serum mitochondrial aspartate aminotransferase as a marker of chronic alcoholism: Diagnostic value and interpretation in a liver unit , 1986, Hepatology.

[183]  T. Tosch,et al.  Significance of megamitochondria in alcoholic liver disease. , 1986, Gastroenterology.

[184]  J. Pignon,et al.  Prognostic value of serum fibronectin concentration in alcoholic cirrhotic patients , 1985, Hepatology.

[185]  C. Lieber,et al.  Perivenular fibrosis as precursor lesion of cirrhosis. , 1985, JAMA.

[186]  A. Lonardo,et al.  [Variability of the clinical and laboratory aspects in the presentation of chronic liver diseases in relation to their etiology. Analysis of a case study and review of the literature]. , 1985, Minerva medica.

[187]  L. Seeff,et al.  Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. , 1984, The New England journal of medicine.

[188]  J. Ewing,et al.  Detecting alcoholism. The CAGE questionnaire. , 1984, JAMA.

[189]  ThorkildI. A. Sørensen,et al.  PROSPECTIVE EVALUATION OF ALCOHOL ABUSE AND ALCOHOLIC LIVER INJURY IN MEN AS PREDICTORS OF DEVELOPMENT OF CIRRHOSIS , 1984, The Lancet.

[190]  T. Poynard,et al.  Prognostic Value of Total Serum Bilirubin/γ‐Glutamyl Transpeptidase Ratio in Cirrhotic Patients , 1984, Hepatology.

[191]  C. Mendenhall,et al.  Protein-calorie malnutrition associated with alcoholic hepatitis. Veterans Administration Cooperative Study Group on Alcoholic Hepatitis. , 1984, The American journal of medicine.

[192]  L. Midanik The validity of self-reported alcohol consumption and alcohol problems: a literature review. , 1982, British journal of addiction.

[193]  H A Skinner,et al.  Reliability of alcohol use indices. The Lifetime Drinking History and the MAST. , 1982, Journal of studies on alcohol.

[194]  C. Lieber,et al.  Perivenular fibrosis in alcoholic liver injury: ultrastructure and histologic progression. , 1982, Gastroenterology.

[195]  I. Maltzman,et al.  Controlled drinking by alcoholics? New findings and a reevaluation of a major affirmative study. , 1982, Science.

[196]  A. Eddleston,et al.  Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis. , 1982, Gut.

[197]  J. Saunders,et al.  Do women develop alcoholic liver disease more readily than men? , 1981, British medical journal.

[198]  Jerold A. Cohen,et al.  The SGOT/SGPT ratio—An indicator of alcoholic liver disease , 1979, Digestive Diseases and Sciences.

[199]  D. Kershenobich,et al.  Treatment of cirrhosis with colchicine. A double-blind randomized trial. , 1979, Gastroenterology.

[200]  J. E. Hardison,et al.  The importance of a coexistent hepatic rub and bruit. A clue to the diagnosis of cancer in the liver. , 1979, JAMA.

[201]  J. Boyer,et al.  Nonalcoholic liver disease: Overlooked causes of liver injury in patients with heavy alcohol consumption , 1979 .

[202]  M. Uribe,et al.  Oral prednisone for chronic active liver disease: dose responses and bioavailability studies. , 1978, Gut.

[203]  Willis C. Maddrey,et al.  Corticosteroid therapy of alcoholic hepatitis. , 1978, Gastroenterology.

[204]  F. Iber,et al.  A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis. With a note on published results in encephalopathic patients. , 1978, The American journal of gastroenterology.

[205]  H. Fallon,et al.  Treatment of alcoholic hepatitis with encephalopathy. Comparison of prednisolone with caloric supplements. , 1978, Gastroenterology.

[206]  S. Sherlock,et al.  Studies in alcoholic liver disease in Britain , 1974, Gut.

[207]  R. N. Macsween,et al.  Hepatic cirrhosis: A clinico-pathological review of 520 cases , 1973, Journal of clinical pathology.

[208]  T. Reynolds,et al.  Prednisone therapy of acute alcoholic hepatitis. Report of a controlled trial. , 1973 .

[209]  D. W. Goodwin,et al.  Alcohol problems in adoptees raised apart from alcoholic biological parents. , 1973, Archives of general psychiatry.

[210]  J. Galambos Natural history of alcoholic hepatitis. 3. Histological changes. , 1972, Gastroenterology.

[211]  J. Galambos,et al.  Natural history of alcoholic hepatitis. II. The long-term prognosis. , 1971, The American journal of gastroenterology.

[212]  C. Pope,et al.  Corticosteroid therapy in severe alcoholic hepatitis. A double-blind drug trial. , 1971, The New England journal of medicine.

[213]  J. Galambos,et al.  Natural history of alcoholic hepatitis , 1971, The American Journal of Digestive Diseases.

[214]  S. Zoneraich,et al.  Diagnostic Significance of Abdominal Arterial Murmurs in Liver and Pancreatic Disease , 1971, Angiology.

[215]  H. Fallon,et al.  Alcoholic hepatitis. Natural history and evaluation of prednisolone therapy. , 1971, Annals of internal medicine.

[216]  C. H. Patrick Alcohol, Culture, and Society, , 1970 .

[217]  L. Goldstein Enlarged, tortuous arteries and hepatic bruit. , 1968, JAMA.

[218]  C. Mendenhall Anabolic steroid therapy as an adjunct to diet in alcoholic hepatic steatosis , 1968, The American Journal of Digestive Diseases.

[219]  W. J. Powell,et al.  Duration of survival in patients with Laennec's cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease. , 1968, The American journal of medicine.

[220]  C. Lieber,et al.  EFFECTS OF PROLONGED ETHANOL INTAKE: PRODUCTION OF FATTY LIVER DESPITE ADEQUATE DIETS. , 1965, The Journal of clinical investigation.

[221]  C. M. Leevy FATTY LIVER: A STUDY OF 270 PATIENTS WITH BIOPSY PROVEN FATTY LIVER AND A REVIEW OF THE LITERATURE , 1962 .

[222]  THE WORLD HEALTH ORGANIZATION , 1954 .

[223]  R. Brůha,et al.  Alcoholic liver disease. , 2012, World journal of hepatology.

[224]  M. Savolainen,et al.  Biochemical markers of alcoholism , 2007, Clinical chemistry and laboratory medicine.

[225]  T. Umemura,et al.  Severe alcoholic hepatitis with extremely high neutrophil count successfully treated by granulocytapheresis. , 2006, Internal medicine.

[226]  The Role of Biomarkers in the Treatment of Alcohol Use Disorders, 2012 Revision , 2006 .

[227]  A. Rambaldi,et al.  S-adenosyl-L-methionine for alcoholic liver diseases. , 2006, The Cochrane database of systematic reviews.

[228]  R. Schwabe,et al.  Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[229]  F. W. Hoffbauer Liver disease , 2005, The American Journal of Digestive Diseases.

[230]  M. Uribe,et al.  Alcoholic liver disease. An update. , 2005, Annals of hepatology.

[231]  F. Gudé,et al.  Liver disease in heavy drinkers with and without alcohol withdrawal syndrome. , 2004, Alcoholism, clinical and experimental research.

[232]  F. Buntinx,et al.  The value of the CAGE in screening for alcohol abuse and alcohol dependence in general clinical populations: a diagnostic meta-analysis. , 2004, Journal of clinical epidemiology.

[233]  D. Crabb,et al.  Recent Advances in Alcoholic Liver Disease , 2004 .

[234]  Roger Williams,et al.  Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis. , 2003, Journal of hepatology.

[235]  P. Brissot,et al.  Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timing. , 2002, Journal of hepatology.

[236]  S. Stewart Racial and ethnic differences in alcohol-associated aspartate aminotransferase and gamma-glutamyltransferase elevation. , 2002, Archives of internal medicine.

[237]  C. Gluud,et al.  Propylthiouracil for alcoholic liver disease. , 2002, The Cochrane database of systematic reviews.

[238]  L. Midanik,et al.  A 10-year national trend study of alcohol consumption, 1984-1995: is the period of declining drinking over? , 2000, American journal of public health.

[239]  B. Grant,et al.  Withdrawal and tolerance: prognostic significance in DSM-IV alcohol dependence. , 2000, Journal of studies on alcohol.

[240]  J. Eisenberg Agency for Health Care Policy and Research. , 1999, Medical care.

[241]  H Wechsler,et al.  Binge drinking: the five/four measure. , 1998, Journal of studies on alcohol.

[242]  K. Bush,et al.  Screening for problem drinking : Comparison of CAGE and AUDIT. , 1998, Journal of general internal medicine.

[243]  R. Hultcrantz,et al.  Chronic hepatitis C in alcoholic patients: prevalence, genotypes, and correlation to liver disease. , 1995, Scandinavian journal of gastroenterology.

[244]  American Gastroenterological Association policy statement on the use of medical practice guidelines by managed care organizations and insurance carriers. , 1995, Gastroenterology.

[245]  C. Naylor The rational clinical examination. Physical examination of the liver. , 1994, JAMA.

[246]  B. Grant,et al.  Prevalence of DSM-IV Alcohol Abuse and Dependence , 1994, Alcohol health and research world.

[247]  P. Hall Pathological spectrum of alcoholic liver disease. , 1994, Alcohol and alcoholism (Oxford, Oxfordshire). Supplement.

[248]  P. Chou,et al.  Prevalence of DSM-IV Alcohol Abuse and Dependence: United States, 1992. , 1994 .

[249]  M. Zillikens,et al.  Nocturnal oral glucose supplementation. The effects on protein metabolism in cirrhotic patients and in healthy controls. , 1993, Journal of hepatology.

[250]  T. Blaschke,et al.  Accelerated improvement of alcoholic liver disease with enteral nutrition. , 1992, Gastroenterology.

[251]  F. Grémy,et al.  [Corticoid therapy in the treatment of acute alcoholic hepatitis. Results of a meta-analysis]. , 1991, Gastroenterologie clinique et biologique.

[252]  J. Levine,et al.  The relative value of consultation, questionnaires and laboratory investigation in the identification of excessive alcohol consumption. , 1990, Alcohol and alcoholism.

[253]  P. Gartside,et al.  Prognostic significance of cholestatic alcoholic hepatitis. VA Cooperative Study Group #119. , 1990, Digestive diseases and sciences.

[254]  A. Nanji,et al.  Serum aspartate aminotransferase to alanine aminotransferase ratio in human and experimental alcoholic liver disease: relationship to histologic changes. , 1989, Enzyme.

[255]  Roger Williams,et al.  Factors determining cirrhosis in alcoholic liver disease. , 1988, Molecular aspects of medicine.

[256]  A. Medline,et al.  Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis. , 1987, Gastroenterology.

[257]  J. Kaprio,et al.  Social and genetic influences on drinking patterns of adult men: a study of 5638 Finnish twin brothers. , 1987, Alcohol and alcoholism (Oxford, Oxfordshire). Supplement.

[258]  A. Chlumská,et al.  [Alcoholic hepatitis]. , 1987, Casopis lekaru ceskych.

[259]  J. Caballería,et al.  Histological course of alcoholic hepatitis. Influence of abstinence, sex and extent of hepatic damage. , 1986, Journal of hepatology.

[260]  T. Peters,et al.  Liver volume measurement by ultrasonography in normal subjects and alcoholic patients. , 1986, Journal of hepatology.

[261]  Roger Williams,et al.  Controlled trial of nutritional supplementation, with and without branched chain amino acid enrichment, in treatment of acute alcoholic hepatitis. , 1985, Journal of hepatology.

[262]  E. Mezey Commentary on the hypermetabolic state and the role of oxygen in alcohol-induced liver injury. , 1984, Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism.

[263]  R. Peters,et al.  Alcoholic foamy degeneration--a pattern of acute alcoholic injury of the liver. , 1983, Gastroenterology.

[264]  J. Henderson,et al.  Enteral hyperalimentation in undernourished patients with cirrhosis and ascites. , 1982, The American journal of clinical nutrition.

[265]  P. Scheuer,et al.  The morphology of alcoholic liver disease. , 1982, British medical bulletin.

[266]  S. Borowsky,et al.  Continued heavy drinking and survival in alcoholic cirrhotics. , 1981, Gastroenterology.

[267]  Alcoholic liver disease: morphological manifestations. Review by an international group. , 1981, Lancet.

[268]  M. Omata,et al.  Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy. , 1980, Gastroenterology.

[269]  J. Galambos Alcoholic hepatitis: its therapy and prognosis. , 1972, Progress in liver diseases.

[270]  C. M. Leevy Fatty liver: a study of 270 patients with biopsy proven fatty liver and review of the literature. , 1962, Medicine.